Plain-English translation of NCT06771219 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a new cancer medication called to see how well it works and how safe it is in people with advanced cancers that have spread to other parts of the body or come back after treatment. Researchers will start by giving participants small doses of the medication and gradually increase the dose to find the right amount that helps fight cancer while keeping side effects manageable. This is an early-stage trial, meaning the medication is still being studied in humans for the first time.
People with advanced cancer often need new treatment options because existing therapies may stop working or cause too many side effects. This trial is designed to find out if this new medication could be a helpful option for patients like you.
You likely qualify if…
You likely don't qualify if…
You will receive the medication as an intravenous infusion (through an IV in your arm) in 3-week cycles, meaning you get one treatment every 3 weeks. You will continue receiving the treatment as long as it appears to be helping and you are tolerating it well. Throughout the trial, you will have regular visits for blood tests, scans to measure your cancer, and a tumor biopsy sample (a small piece of tissue taken from your cancer) so researchers can study how the medication affects your cancer cells.
AI-generated summary from trial data · Aug 13, 2026 · Not medical advice
United States